Savara Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting a net loss of $42,989 thousand for the third quarter and $120,501 thousand for the nine months ended September 30, 2026.

Key Highlights

  • Third-quarter net loss: The company reported a net loss of $42,989 thousand for the three months ended September 30, 2026, compared to $29,561 thousand in the same period of 2025.
  • Nine-month net loss: For the nine months ended September 30, 2026, the net loss totaled $120,501 thousand, up from $86,601 thousand for the same period of 2025.
  • Cash and investments: As of September 30, 2026, the company held $29,812 thousand in cash and cash equivalents and $99,837 thousand in short-term investments, down from $33,180 thousand and $202,522 thousand, respectively, at December 31, 2025.
  • Total assets declined: Total assets were $155,933 thousand as of September 30, 2026, compared to $253,436 thousand at December 31, 2025.
  • Accumulated deficit grew: The accumulated deficit reached $728,588 thousand as of September 30, 2026, versus $608,087 thousand at December 31, 2025.
  • Shares outstanding: As of November 9, 2026, the registrant had 220,623,511 shares of common stock outstanding.
  • Operating expenses rose: Total operating expenses for the nine months ended September 30, 2026 were $123,497 thousand, compared to $90,128 thousand for the same period of 2025, driven by increases in both research and development and general and administrative costs.

Savara's Financial Position and Operating Results for the Quarter Ended September 30, 2026

According to the filing, Savara Inc. (NASDAQ:SVRA) reported a net loss of $42,989 thousand for the three months ended September 30, 2026, compared to a net loss of $29,561 thousand for the three months ended September 30, 2025. For the nine-month period, the net loss was $120,501 thousand versus $86,601 thousand in the prior year period. Basic and diluted net loss per share was $(0.17) for the third quarter of 2026 and $(0.47) for the nine months ended September 30, 2026, based on weighted-average shares outstanding of 254,219,719 and 253,799,570, respectively, the company disclosed.

The filing shows that total operating expenses for the three months ended September 30, 2026 were $43,542 thousand, compared to $30,255 thousand in the same quarter of 2025. Research and development expenses for the quarter were $24,945 thousand, up from $20,592 thousand, while general and administrative expenses increased to $18,541 thousand from $9,627 thousand. For the nine-month period, research and development expenses were $70,294 thousand and general and administrative expenses were $53,095 thousand, according to the filing.

As of September 30, 2026, the company reported total stockholders' equity of $107,850 thousand, down from $203,133 thousand at December 31, 2025. Total liabilities were $48,083 thousand, including long-term debt of $30,242 thousand. The authorized shares of common stock increased to 600,000,000 as of September 30, 2026, from 300,000,000 as of December 31, 2025, with 205,536,152 shares issued and outstanding at September 30, 2026, the filing stated. Stock-based compensation for the nine months ended September 30, 2026 totaled $26,319 thousand across the three quarters, as reflected in the equity statement.

What Was Disclosed

Savara Inc. filed its quarterly report for the period ended September 30, 2026, disclosing a third-quarter net loss of $42,989 thousand, a nine-month net loss of $120,501 thousand, declining cash and investment balances, and an accumulated deficit of $728,588 thousand, with 220,623,511 shares outstanding as of November 9, 2026.